Q&A: Blood test preferred over FIT, colonoscopy for CRC screening

Epigenomics AG found most patients prefer the Epi proColon blood test for colorectal cancer screening vs. fecal immunochemical tests and colonoscopy screening, according to a report published in Journal of the National Cancer Institute.Healio Gastroenterology spoke with Greg Hamilton, CEO of Epigenomics AG, to discuss the study results and next steps.Healio: What was the purpose and design of the study?Hamilton: The purpose was to determine which of the available alternatives to FIT and colonoscopy is the most promising from a cost-effectiveness perspective.Investigators used the cancerRead More

Share on facebook
Share on twitter
Share on linkedin